$MINM
MINIM, INC. Stock $minm

$minm Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000182912624002449 Filed on April 12, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue		$1.464M	$26.11M
YoY Change		-86.23%	-48.43%
Cost Of Revenue		$1.090M	$25.64M
YoY Change		-87.2%	-33.75%
Gross Profit		$373.7K	$470.9K
YoY Change		-82.32%	-96.05%
Gross Profit Margin		25.53%	1.8%
Selling, General & Admin	$611.6K	$1.385M	$14.23M
YoY Change	-87.15%	-71.56%	-32.7%
% of Gross Profit		370.53%	3022.12%
Research & Development		$88.32K	$3.447M
YoY Change		-94.47%	-40.83%
% of Gross Profit		23.63%	731.93%
Depreciation & Amortization		$171.6K	$612.1K
YoY Change		-22.19%	51.9%
% of Gross Profit		45.92%	130.0%
Operating Expenses	$488.5K	$1.473M	$17.68M
YoY Change	-91.78%	-77.22%	-34.46%
Operating Profit	-$488.5K	-$1.099M	-$17.21M
YoY Change	-91.05%	-74.74%	14.37%
Interest Expense	-$20.00	-$26.76K	-$383.4K
YoY Change	-100.02%	-79.78%	-197.16%
% of Operating Profit
Other Income/Expense, Net	$20.00	-$1.320K	-$1.320K
YoY Change	-100.02%	-157.39%	-99.66%
Pretax Income	-$488.5K	-$1.127M	-$17.59M
YoY Change	-91.23%	-74.85%	13.96%
Income Tax	-$554.00	$18.17K	$42.62K
% Of Pretax Income
Net Earnings	-$487.9K	-$1.146M	-$17.63M
YoY Change	-91.28%	-74.67%	13.41%
Net Earnings / Revenue		-78.27%	-67.55%
Basic Earnings Per Share	-$0.17		-$9.08
Diluted Earnings Per Share	-$0.17	-$0.54	-$9.08
COMMON SHARES
Basic Shares Outstanding	2.966M shares	1.898M shares	1.942M shares
Diluted Shares Outstanding	2.810M shares		1.942M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$709.3K	$709.3K
YoY Change		33.81%	33.81%
Cash & Equivalents	$630.8K	$709.3K	$709.3K
Short-Term Investments
Other Short-Term Assets		$35.77K	$35.77K
YoY Change		-95.84%	-95.84%
Inventory		$9.953M	$9.953M
Prepaid Expenses
Receivables		$701.4K	$701.4K
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$654.9K	$11.40M	$11.40M
YoY Change	-96.94%	-61.44%	-61.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$264.0K	$455.0K	$455.0K
YoY Change	-57.26%	-28.57%	-43.86%
Goodwill
YoY Change
Intangibles	$0.00	$33.25K
YoY Change	-100.0%	-54.64%
Long-Term Investments
YoY Change
Other Assets	$34.38K	$472.6K	$472.6K
YoY Change	-94.12%	-7.66%	-7.66%
Total Long-Term Assets	$298.4K	$960.9K	$960.9K
YoY Change	-77.7%	-31.15%	-31.15%
TOTAL ASSETS
Total Short-Term Assets	$654.9K	$11.40M	$11.40M
Total Long-Term Assets	$298.4K	$960.9K	$960.9K
Total Assets	$953.3K	$12.36M	$12.36M
YoY Change	-95.81%	-60.08%	-60.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$263.7K	$11.14M	$11.14M
YoY Change	-96.98%	292.77%	292.77%
Accrued Expenses	$1.094M	$1.100M	$1.100M
YoY Change	-48.61%	-75.22%	-76.04%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.358M	$12.24M	$12.24M
YoY Change	-91.05%	-11.41%	-11.41%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Total Long-Term Liabilities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.358M	$12.24M	$12.24M
Total Long-Term Liabilities		$0.00	$0.00
Total Liabilities	$1.358M	$12.24M	$12.24M
YoY Change	-91.44%	-16.22%	-16.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$96.22M	-$92.47M
YoY Change	13.86%	23.62%
Common Stock	$481.1K	$479.3K
YoY Change	1.95%	2.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$404.7K	$115.9K	$115.9K
YoY Change
Total Liabilities & Shareholders Equity	$953.3K	$12.36M	$12.36M
YoY Change	-95.81%	-60.08%	-60.08%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$487.9K	-$1.146M	-$17.63M
YoY Change	-91.28%	-74.67%	13.41%
Depreciation, Depletion And Amortization		$171.6K	$612.1K
YoY Change		-22.19%	51.9%
Cash From Operating Activities		$1.140M	$4.850M
YoY Change		-261.16%	-139.75%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$162.3K
YoY Change		-100.0%	-41.35%
Acquisitions
YoY Change
Other Investing Activities		$0.00	-$219.6K
YoY Change		-100.0%	-47.51%
Cash From Investing Activities		$0.00	-$381.9K
YoY Change		-100.0%	-45.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-896.8K	-4.788M
YoY Change		763.39%	-680.59%
NET CHANGE
Cash From Operating Activities		1.140M	4.850M
Cash From Investing Activities		0.000	-381.9K
Cash From Financing Activities		-896.8K	-4.788M
Net Change In Cash		243.2K	-320.8K
YoY Change		-126.79%	-97.34%
FREE CASH FLOW
Cash From Operating Activities		$1.140M	$4.850M
Capital Expenditures		$0.00	$162.3K
Free Cash Flow		$1.140M	$4.687M
YoY Change		-255.86%	-137.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001467761
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent		usd
CY2023Q4	us-gaap	Bridge Loan BridgeLoan		usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures		usd
CY2023	MINM	Amortization Of Sales Contract Costs AmortizationOfSalesContractCosts		usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue		usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment		shares
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability		usd
CY2023Q4	MINM	Accrued Inventory Purchases Current And Noncurrent AccruedInventoryPurchasesCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent		usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent		usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2022	MINM	Federal Tax Expense Benefit FederalTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit		usd
CY2023	MINM	Federal Tax Expense Benefit FederalTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment		usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	5100000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2965900	shares
CY2023	dei	Auditor Firm AuditorFirmId	5041
CY2023	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2023	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	709322	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530110	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	312983	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	138331	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	701377	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2758406	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	9952647	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	25415206	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35768	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	360735	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	11399114	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	29564457	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	432505	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636973	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	22512	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	173480	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	33247	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	73301	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	472587	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	511795	usd
CY2023Q4	us-gaap	Assets Assets	12359965	usd
CY2022Q4	us-gaap	Assets Assets	30960006	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4758663	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11143693	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2837191	usd
CY2022Q4	us-gaap	Bridge Loan BridgeLoan	1000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22512	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	150968	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1077843	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4440724	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633542	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12244048	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13821088	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22512	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	771738	usd
CY2023Q4	us-gaap	Liabilities Liabilities	12244048	usd
CY2022Q4	us-gaap	Liabilities Liabilities	14615338	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2632809	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2632809	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1877970	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1877970	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	479335	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	469492	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	92105360	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	90710030	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92468778	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74834854	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	115917	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16344668	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12359965	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30960006	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26106271	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50622143	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	25635383	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	38695605	usd
CY2023	us-gaap	Gross Profit GrossProfit	470888	usd
CY2022	us-gaap	Gross Profit GrossProfit	11926538	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	67415	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	174652	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9472527	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	15022638	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4758357	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6124034	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3446595	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5824906	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	17677479	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	26971578	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-17206591	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-15045040	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	2554	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	457	usd
CY2023	us-gaap	Interest Expense InterestExpense	385952	usd
CY2022	us-gaap	Interest Expense InterestExpense	394615	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1316	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2302	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-384714	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-391856	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17591305	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15436896	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42619	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112348	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.08
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1941800	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1941800	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1855965	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1855965	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	30486513	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	236804	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1170595	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16344668	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17633924	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	1125778	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	279395	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	115917	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17633924	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	612138	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	837228	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	150968	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	172060	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	29845	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	71401	usd
CY2022	MINM	Amortization Of Sales Contract Costs AmortizationOfSalesContractCosts	75514	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	279395	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1170595	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	-0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	58872	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-98489	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	1785566	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1882377	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2220746	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15462559	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6690515	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-324963	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-227150	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-53458	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-63044	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8306503	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-9621054	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3237131	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-839265	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1405280	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	670532	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-150968	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-172659	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4849555	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12170073	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	162270	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	276665	usd
CY2023	MINM	Certification Costs Incurred And Capitalized CertificationCostsIncurredAndCapitalized	219595	usd
CY2022	MINM	Certification Costs Incurred And Capitalized CertificationCostsIncurredAndCapitalized	418352	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-381865	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-695017	usd
CY2023	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	-4788478	usd
CY2022	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	-377811	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1000000	usd
CY2022	us-gaap	Payments For Proceeds From Deposit On Loan PaymentsForProceedsFromDepositOnLoan	34237	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	236803	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4788478	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	824755	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-320788	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12040335	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1030110	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13070445	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	709322	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1030110	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	238329	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	394615	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	42619	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	88348	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	709322	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	530110	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	500000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	709322	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1030110	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	709322	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17633924	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17633924	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4849555	usd
CY2023	MINM	Cash From Investing And Financing Activities CashFromInvestingAndFinancingActivities	5200000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-92468778	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	709322	usd
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	25:1 reverse stock split
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	500000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84A_eus-gaap--ConcentrationRiskCreditRisk_zoraQwFxaUM" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i><span id="xdx_867_zvbIlesLiLE2">Concentration of Credit Risk</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, restricted cash and accounts receivable. Substantially all the Company’s cash and cash equivalents and restricted cash are held at one financial institution, Silicon Valley Bank, which was placed into receivership by the FDIC on March 9, 2023. On March 10, 2023, the Silicon Valley Bank depositor accounts and loan facilities, including the Company’s bank accounts and line of credit, were transferred to Silicon Valley Bridge Bank. Through Silicon Valley Bridge Bank, the Company’s bank balances are fully insured by the FDIC and the line of credit facility remains operational, allowing the Company to draw from it as required. The Company has not experienced any credit losses on its cash and cash equivalents and restricted cash through December 31, 2023 and has not experienced any credit losses as of the date of filing this Form 10-K</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the year ended December 31, 2023, two customers accounted for 10% or greater individually, and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_pdd" title="Concentration risk percentage">80%</span> in the aggregate of the Company’s total net sales. For the year ended December 31, 2022, two customers accounted for 10% or greater individually, and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_pdd" title="Concentration risk percentage">87%</span> in the aggregate of the Company’s total net sales. Accounts receivable are unsecured and the Company does not require collateral; however, the Company does assess the collectability of accounts receivable based on a number of factors, including past transaction history with, and the creditworthiness of, the customer. Accordingly, the Company is exposed to credit risk associated with accounts receivable. At December 31, 2023, one customer with an accounts receivable balance of 10% or greater individually accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomersMember_zPWKESz10Tj1" title="Concentration risk percentage">96%</span> of the Company’s accounts receivable. At December 31, 2022, two customers with an accounts receivable balance of 10% or greater individually accounted for a combined <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoCustomersMember_zfQMuTNto7E4" title="Concentration risk percentage">75%</span> of the Company’s accounts receivable. To reduce risk, the Company closely monitors the amounts due from its customers and assesses the financial strength of its customers through a variety of methods that include, but are not limited to, engaging directly with customer operations and leadership personnel, visiting customer locations to observe operating activities, and assessing customer longevity and reputation in the marketplace. As a result, the Company believes that its accounts receivable credit risk exposure is limited.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The Company depends on many third-party suppliers for key components contained in its product offerings. For some of these components, the Company may only use a single source supplier, in part due to the lack of alternative sources of supply. During 2023 and 2022, the Company had one and two suppliers that provided <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--OneSupplierMember_pdd" title="Concentration risk percentage">86%</span> and <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis__custom--OneSupplierMember_pdd" title="Concentration risk percentage">93%</span>, respectively, of the Company’s purchased inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	58872	usd
CY2023Q4	MINM	Capitalized Implementation Costs CapitalizedImplementationCosts	0	usd
CY2022Q4	MINM	Capitalized Implementation Costs CapitalizedImplementationCosts	0	usd
CY2023Q4	MINM	Net Of Accumulated Amortization Of Certification Costs NetOfAccumulatedAmortizationOfCertificationCosts	417000	usd
CY2022Q4	MINM	Net Of Accumulated Amortization Of Certification Costs NetOfAccumulatedAmortizationOfCertificationCosts	402000	usd
CY2023Q4	MINM	Net Of Accumulated Amortization For Longterm Insurance Policies NetOfAccumulatedAmortizationForLongtermInsurancePolicies	47000	usd
CY2022Q4	MINM	Net Of Accumulated Amortization For Longterm Insurance Policies NetOfAccumulatedAmortizationForLongtermInsurancePolicies	71000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-17633924	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-15549244	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1941800	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1855965	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1941800	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1855965	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-9.08
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-9.08
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.38
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.38
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	36318	shares
CY2023Q4	MINM	Sales Return Accrual SalesReturnAccrual	578000	usd
CY2022Q4	MINM	Sales Return Accrual SalesReturnAccrual	982000	usd
CY2023Q4	MINM	Accrual Promotion Rebate AccrualPromotionRebate	0	usd
CY2022Q4	MINM	Accrual Promotion Rebate AccrualPromotionRebate	0	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2023	us-gaap	Advertising Expense AdvertisingExpense	2000000.0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	4000000.0	usd
CY2023	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	363000	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	452000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	701377	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2758406	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	633542	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	771738	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1405280	usd
CY2023	MINM	Contract With Customer Liability Revenue Recognized Billings ContractWithCustomerLiabilityRevenueRecognizedBillings	767832	usd
CY2023	MINM	Revenue Recognized RevenueRecognized	-2173112	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26106271	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50622143	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	26106271	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50622143	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	210318	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	397133	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1640347	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	5842251	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	8101982	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	19175822	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	9952647	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	25415206	usd
CY2023Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	0	usd
CY2022Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	4200000	usd
CY2023Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	1700000	usd
CY2022Q4	us-gaap	Other Inventory Net Of Reserves OtherInventoryNetOfReserves	2500000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2652020	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2489750	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2219515	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1852777	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	432505	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	636973	usd
CY2023	us-gaap	Depreciation Depreciation	368000	usd
CY2022	us-gaap	Depreciation Depreciation	403000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	86732	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-53485	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33247	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	316838	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-243537	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	73301	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	17346	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	15901	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33247	usd
CY2022Q4	MINM	Accrued Inventory Purchases Current And Noncurrent AccruedInventoryPurchasesCurrentAndNoncurrent	24901	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	430358	usd
CY2023Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	229950	usd
CY2022Q4	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	290588	usd
CY2022Q4	us-gaap	Accrued Royalties Current And Noncurrent AccruedRoyaltiesCurrentAndNoncurrent	1650000	usd
CY2023Q4	MINM	Accrued Sales Allowances Current And Noncurrent AccruedSalesAllowancesCurrentAndNoncurrent	697884	usd
CY2022Q4	MINM	Accrued Sales Allowances Current And Noncurrent AccruedSalesAllowancesCurrentAndNoncurrent	1226856	usd
CY2023Q4	MINM	Accrued Sales And Use Tax Current And Noncurrent AccruedSalesAndUseTaxCurrentAndNoncurrent	150009	usd
CY2022Q4	MINM	Accrued Sales And Use Tax Current And Noncurrent AccruedSalesAndUseTaxCurrentAndNoncurrent	113200	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	704821	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	1077843	usd
CY2022Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4440724	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	0	usd
CY2022Q4	us-gaap	Loans Payable LoansPayable	0	usd
CY2021Q4	us-gaap	Operating Lease Payments Use OperatingLeasePaymentsUse	9000	usd
CY2021Q4	us-gaap	Variable Lease Payment VariableLeasePayment	5000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	155379	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	181361	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41550	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	29740	usd
CY2023	us-gaap	Lease Cost LeaseCost	196929	usd
CY2022	us-gaap	Lease Cost LeaseCost	211101	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P0Y4M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042	pure
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	150968	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	172730	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	103914	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	22794	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	22794	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	282	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	22512	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	22512	usd
CY2023	us-gaap	Royalty Expense RoyaltyExpense	6600000	usd
CY2022	us-gaap	Royalty Expense RoyaltyExpense	6600000	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	5000000.0	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	25:1 reverse stock split
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	60000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2632809	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1877970	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	94583	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	36.75
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10.50	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	17233	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	13.75
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	38424	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	36.75
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	38926	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.75
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y2M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10.50	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	38926	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	46.75
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	140000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	162000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	710000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2023	MINM	Grant Stock Options GrantStockOptions	0	shares
CY2022	MINM	Grant Stock Options GrantStockOptions	0	shares
CY2023	MINM	Value Stock Options ValueStockOptions	0	shares
CY2022	MINM	Value Stock Options ValueStockOptions	0	shares
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	48956	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	31.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	34080	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	15.50
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	25331	shares
CY2022	MINM	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionVestedInPeriodWeightedAverageGrantDateFairValue	21.00
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	13189	shares
CY2022	MINM	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionForfeituresWeightedAverageGrantDateFairValue	34.75
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	44516	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.75
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	14831	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.39
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	120661	usd
CY2023Q4	MINM	Deferred Tax Assets Interest Expense Other DeferredTaxAssetsInterestExpenseOther	293932	usd
CY2022Q4	MINM	Deferred Tax Assets Interest Expense Other DeferredTaxAssetsInterestExpenseOther	187990	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20464729	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	17839656	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20464729	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17839656	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	38500000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	20498	shares
CY2023	MINM	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionVestedInPeriodWeightedAverageGrantDateFairValue	-21.63
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	38849	shares
CY2023	MINM	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Option Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionForfeituresWeightedAverageGrantDateFairValue	-17.86
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	279395	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1170595	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	59846	usd
CY2022	MINM	State And Local Tax Expense Benefit StateAndLocalTaxExpenseBenefit	59846	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	52502	usd
CY2022	MINM	Foreign Tax Expense Benefit ForeignTaxExpenseBenefit	52502	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	112348	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	112348	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	16623	usd
CY2023	MINM	State And Local Tax Expense Benefit StateAndLocalTaxExpenseBenefit	16623	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	25996	usd
CY2023	MINM	Foreign Tax Expense Benefit ForeignTaxExpenseBenefit	25996	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42619	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	42619	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	1234710	usd
CY2023Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	550023	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	889821	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	261564	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	357920	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	29414	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	266665	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19244464	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14742578	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	85332	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	39311	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.04	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.01	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.09	pure
CY2023	MINM	Expiration Of Net Operating Loss ExpirationOfNetOperatingLoss	-0.05	pure
CY2022	MINM	Expiration Of Net Operating Loss ExpirationOfNetOperatingLoss	-0.13	pure
CY2023	MINM	Expiration Of Stock Options ExpirationOfStockOptions	0.01	pure
CY2022	MINM	Expiration Of Stock Options ExpirationOfStockOptions	0.14	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.01	pure
CY2023	MINM	Changes In Federal And State Rates ChangesInFederalAndStateRates	0.01	pure
CY2022	MINM	Changes In Federal And State Rates ChangesInFederalAndStateRates	0.01	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.01	pure
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2022Q1	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03	pure
CY2022	MINM	Defined Contribution Plan Maximum Wages Annual Contributions Per Employee Amount DefinedContributionPlanMaximumWagesAnnualContributionsPerEmployeeAmount	20500	usd
CY2023	MINM	Defined Contribution Plan Maximumcontribute An Additional Amount DefinedContributionPlanMaximumcontributeAnAdditionalAmount	6500	usd
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount	22500	usd
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	98000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	179000	usd
CY2023Q4	us-gaap	Area Of Land AreaOfLand	2656
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	42000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	33000	usd

Files In Submission

Name	View Source	Status
0001829126-24-002449-index-headers.html	Edgar Link	pending
0001829126-24-002449-index.html	Edgar Link	pending
0001829126-24-002449.txt	Edgar Link	pending
0001829126-24-002449-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
img_003.jpg	Edgar Link	pending
img_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
miniminc_10k.htm	Edgar Link	pending
miniminc_ex21-1.htm	Edgar Link	pending
miniminc_ex23-1.htm	Edgar Link	pending
miniminc_ex23-2.htm	Edgar Link	pending
miniminc_ex31-1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
miniminc_10k_htm.xml	Edgar Link	completed
miniminc_ex32-1.htm	Edgar Link	pending
miniminc_ex97-1.htm	Edgar Link	pending
minm-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
minm-20231231_def.xml	Edgar Link	unprocessable
minm-20231231_lab.xml	Edgar Link	unprocessable
minm-20231231_pre.xml	Edgar Link	unprocessable
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
minm-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MINM
MINIM, INC. Stock $minm

2024 Q2 Form 10-K Financial Statement

#000182912624002449 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MINM MINIM, INC. Stock $minm

2024 Q2 Form 10-K Financial Statement

#000182912624002449 Filed on April 12, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MINM
MINIM, INC. Stock $minm